Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 20 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

30%

6 trials in Phase 3/4

Results Transparency

18%

2 of 11 completed trials have results

Key Signals

5 recruiting2 with results

Enrollment Performance

Analytics

Phase 1

6(35.3%)

Phase 3

3(17.6%)

N/A

3(17.6%)

Phase 4

3(17.6%)

Phase 2

2(11.8%)

17Total

Phase 1(6)

Phase 3(3)

N/A(3)

Phase 4(3)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (20)

Showing 20 of 20 trials

NCT05608148Phase 1Recruiting

Clinical Trial of GAIA-102 for Refractory/Relapse Neuroblastomas and Other Malignant Pediatric Solid Tumors

Role: lead

NCT05438459Phase 1Recruiting

GAIA-102 Intraperitoneal Administration in Patients With Advanced Gastrointestinal Cancer of Microsatellite Stable With Malignant Ascites

Role: lead

NCT06983210Phase 2Recruiting

Clinical Trial of AM80 in Combination With Gemcitabine, Cisplatin, and Nivolumab in Patients With Urothelial Carcinoma

Role: collaborator

NCT05863234Phase 1Recruiting

Safety Evaluation Study for Patients With Aggressive NK-cell Leukemia

Role: collaborator

NCT03620474Phase 1Completed

Safety and Effectiveness of PRI-724 for Hepatitis C or B Virus Derived Liver Cirrhosis

Role: collaborator

NCT02410850Recruiting

Long Term Oral Appliance Therapy Effectiveness for Obstructive Sleep Apnea Syndrome

Role: collaborator

NCT05680623Completed

Clinical and Economic Validation of the ISGPS Definition of PPAP

Role: collaborator

NCT04730037Phase 3Completed

Clinical Trial to Investigate Safety and Efficacy of Edoxaban in Patients With CTEPH (KABUKI)

Role: lead

NCT02276937Phase 2Unknown

Randomized Phase IIb Trial of DVC1-0101

Role: lead

NCT04621136Phase 1Completed

PhaseI/II Investigator-Initiated Trial to Investigate Safety and Efficacy of Ripasudil in Patients With Retinopathy of Prematurity

Role: lead

NCT04686006Completed

Effective Iodide Therapy for Untreated Patients With Graves' Hyperthyroidism Avoiding Thionamide Drugs With Many Side Effects

Role: lead

NCT03144635Phase 4Completed

A Study for G1b CHC Patients With CKD-3 Treated With Grazoprevir Plus Elbasvir

Role: lead

NCT00333164Phase 3Completed

Cilostazol-Aspirin Therapy Against Recurrent Stroke With Intracranial Artery Stenosis

Role: collaborator

NCT02462304Phase 4Unknown

To Compare Anti-VEGF Monotherapy With Anti-VEGF and EPM Grid Laser Combination Therapy for Diabetic Macular Edema

Role: collaborator

NCT01699698Not ApplicableCompleted

Pancreatic Juice Diagnosis From Duodenum

Role: collaborator

NCT02158624Not ApplicableUnknown

Ranibizumab Treatment for Age-Related Macular Degeneretion

Role: lead

NCT01514019Phase 4Completed

An Open-label, Single-dose, Two-treatment, Randomized, Cross-over Study to Investigate the Effects of the SLCO2B1 c.1457C>T Polymorphism and Apple Juice on the Pharmacokinetics and Pharmacodynamics of Acebutolol in Healthy Korean and Japanese Volunteers

Role: collaborator

NCT00676949Phase 1Completed

Safety Study of Cancer Specific Epitope Peptides Cocktail for Cervical, GI, and Lung Tumors

Role: lead

NCT00670787Phase 3Completed

Combination Pill of Losartan Potassium and Hydrochlorothiazide for Improvement of Medication Compliance Trial

Role: lead

NCT00956982Not ApplicableUnknown

PEG-IFN Plus Ribavirin Combination Therapy for Older Patients

Role: lead

All 20 trials loaded